NanoVibronix, Inc. is a medical device company. The Company's products include WoundShield(TM), a patch-based therapeutic ultrasound device which facilitates tissue regeneration and wound healing; PainShield(R), a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures; UroShield(TM), an ultrasound-based product which is designed to prevent biofilm in urinary catheters; NanoVibronix, lightweight pump which allow contamination-free handling of infected wound exudate and enhanced patient mobility. NanoVibronix, Inc. is based in Melville, New York.
| Revenue (Most Recent Fiscal Year) | $2.56M |
| Net Income (Most Recent Fiscal Year) | $-3.70M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.99 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.02 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -209.80% |
| Net Margin (Trailing 12 Months) | -210.82% |
| Return on Equity (Trailing 12 Months) | -54.73% |
| Return on Assets (Trailing 12 Months) | -38.63% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.47 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.22 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 0.65 |
| Book Value per Share (Most Recent Fiscal Quarter) | $1.84 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | -- |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 2.58M |
| Free Float | 2.40M |
| Market Capitalization | $2.64M |
| Average Volume (Last 20 Days) | 9.96M |
| Beta (Past 60 Months) | 1.76 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 7.00% |
| Percentage Held By Institutions (Latest 13F Reports) | 16.39% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |